logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Nutraceutical
Filter

Nutraceutical

Categories

Sectors

Locations

Exchange

豪掷50亿!揭秘礼来继减肥针后的下一个增长引擎

Splashing Out 5 Billion! Unveiling Lilly’s Next Growth Engine After the Weight-Loss Injection

Sep 24, 2025

Life Science

在研药物试验结果积极,Atai Life Sciences股价应声飙升

Positive Results from Investigational Drug Trial, Atai Life Sciences Stock Soars Accordingly

Sep 23, 2025

Life Science

监管利好与分析师看好,BioNTech股价双喜临门

Regulatory Tailwinds and Analyst Optimism: A Double Dose of Good News for BioNTech’s Stock

Sep 23, 2025

Life Science

Debt Gravity and the Seven Fault Lines Exposed

Sep 22, 2025

Life Science

估值高企的礼来,凭什么用AI讲好新故事?

Why Is Overvalued Eli Lilly Using AI to Tell a New Story?

Sep 20, 2025

Life Science

ARM lifts stake to 19.9% in Surge Copper financing

Sep 19, 2025

Life Science

礼来口服减肥药数据强劲,巩固GLP-1市场领先地位

Eli Lilly’s Strong Oral Weight-Loss Drug Data Solidifies Its Leading Position in the GLP-1 Market

Sep 18, 2025

Life Science

后浪来袭,诺和诺德新一代减肥药疗效显著

The Tide of the Next Generation: Novo Nordisk’s New Weight-Loss Drug Shows Remarkable Efficacy

Sep 17, 2025

Life Science

Paladin raises A300m for PLS and Langer Heinrich

Sep 16, 2025

Life Science

谁能挑战注射式减肥药?这家公司把赌注压在了药片上

Who Can Challenge Injectable Weight-Loss Drugs? This Company Is Betting on Pills

Sep 13, 2025

Life Science

Vale S11D license clears 20 Mt iron ore expansion

Sep 12, 2025

Life Science

Asia’s Oil Trade Faces a Surplus China May Not Absorb

Sep 12, 2025

Life Science

新品+独家合作:Hims & Hers拓展男性健康业务推动股价上涨

New + Exclusive Collaboration: Hims & Hers Expands Men’s Health Business to Drive Stock Price Increase

Sep 11, 2025

Life Science

暴跌47%后,联合健康的“护城河”还管用吗?

After a 47% Plunge, Is UnitedHealth’s ‘Moat’ Still Effective?

Sep 9, 2025

Life Science

UKs Nuclear Bet Ignores a 10,000-Year Balance Sheet

Sep 9, 2025

Life Science

减肥药市场生变?诺和诺德手握口服“王牌”

Weight Loss Drug Market Faces Changes? Novo Nordisk Holds the Oral “Key”

Sep 9, 2025

Life Science

分析师看好+临床数据强劲,Relay Therapeutics股价周涨近15%

Analysts Bullish + Strong Clinical Data Send Relay Therapeutics Shares Up Nearly 15% for the Week

Sep 5, 2025

Life Science

Collateral Chains: China Rewrites Sovereign Risk

Sep 5, 2025

Life Science

  • ‹‹ Previous
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada